GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (FRA:HPX) » Definitions » Median PS Value

Hisamitsu Pharmaceutical Co (FRA:HPX) Median PS Value : €29.28 (As of May. 27, 2024)


View and export this data going back to . Start your Free Trial

What is Hisamitsu Pharmaceutical Co Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Hisamitsu Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Nov. 2023 was €11.68. Hisamitsu Pharmaceutical Co's 10-Year median PS Ratio is 2.5068. Therefore, the Median PS Value for today is €29.28.

As of today (2024-05-27), Hisamitsu Pharmaceutical Co's share price is €21.40. Hisamitsu Pharmaceutical Co's Median PS Value is €29.28. Therefore, Hisamitsu Pharmaceutical Co's Price to Median PS Value for today is 0.73.

The historical rank and industry rank for Hisamitsu Pharmaceutical Co's Median PS Value or its related term are showing as below:

FRA:HPX' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.73   Med: 1.05   Max: 1.64
Current: 0.73

During the past 13 years, the highest Price to Median PS Value of Hisamitsu Pharmaceutical Co was 1.64. The lowest was 0.73. And the median was 1.05.

FRA:HPX's Price-to-Median-PS-Value is ranked better than
60.83% of 508 companies
in the Drug Manufacturers industry
Industry Median: 0.83 vs FRA:HPX: 0.73

Hisamitsu Pharmaceutical Co Median PS Value Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Median PS Value Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.20 32.60 33.43 32.78 -

Hisamitsu Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.78 32.33 30.48 30.77 -

Competitive Comparison of Hisamitsu Pharmaceutical Co's Median PS Value

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hisamitsu Pharmaceutical Co's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's Price-to-Median-PS-Value falls into.



Hisamitsu Pharmaceutical Co Median PS Value Calculation

Hisamitsu Pharmaceutical Co's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=11.68*2.5068
=29.28

10-Year Median PS Ratio is 2.5068.
Hisamitsu Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €11.68.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hisamitsu Pharmaceutical Co  (FRA:HPX) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Hisamitsu Pharmaceutical Co's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=21.40/29.28
=0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hisamitsu Pharmaceutical Co Median PS Value Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Hisamitsu Pharmaceutical Co (FRA:HPX) Business Description

Traded in Other Exchanges
Address
408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.